Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

19 May, 2025, Bengaluru: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.

The inspection was conducted from 17^th March, 2025 to 21^st March, 2025.